Daily BriefsECM

Daily Brief ECM: ATRenew (RERE US): Pre-Owned Satisfaction and more

In today’s briefing:

  • ATRenew (RERE US): Pre-Owned Satisfaction
  • DPC Dash IPO: Dominos Getting Dominated
  • Weilong Delicious Global IPO – Tepid Recent Performance Still Makes It Look Expensive
  • Weilong Delicious IPO: Valuation Insights
  • Baxter International Inc.: Initiation of Coverage – Recent FDA Approvals & Other Drivers

ATRenew (RERE US): Pre-Owned Satisfaction

By Arun George

  • ATRenew (RERE US) operates the largest pre-owned consumer electronics transactions and services platform in China. It is listed in June 2021 at US$14 per ADS. 
  • The shares are down 63% YTD largely due to the tech market sell-off. Unlike most tech companies, ATRenew is starting to deliver growth with profits, cash generation and share buybacks.
  • The valuation is undemanding compared to a peer group of pre-owned marketplaces and global online retail marketplaces. It will also appeal to investors with an ESG mandate.

DPC Dash IPO: Dominos Getting Dominated

By Oshadhi Kumarasiri

  • DPC Dash (DPC HK) is the exclusive master franchisee of Domino’s Pizza (DPZ US) in mainland China, Hong Kong and Macau with around 546 stores as of 9M2022.
  • The company has refiled for an IPO on the Hong Kong Stock Exchange after failing the first time to raise around US $100m in March 2022.
  • Discounted pricing has failed to propel the Dominos brand to the top in many Asian markets where pizza is considered a luxury meal. DPC-Dash is experiencing the same in China.

Weilong Delicious Global IPO – Tepid Recent Performance Still Makes It Look Expensive

By Sumeet Singh

  • Weilong Delicious Global (WDG HK)  a spicy snack food company in China, aims to raise around US$140m in its Hong Kong IPO.
  • According to F&S, WDG ranked first among spicy snack food enterprises in China, with a market share of 6.2%, and in the seasoned flour product and spicy vegetable snacks categories.
  • We have covered various aspects of the deal in our previous notes, in this note, we will talk about  the final valuations.

Weilong Delicious IPO: Valuation Insights

By Arun George


Baxter International Inc.: Initiation of Coverage – Recent FDA Approvals & Other Drivers

By Baptista Research

  • This is our first report on Baxter International, one of the largest players in the domain of dialysis therapies and other healthcare products.
  • The overall demand for products across the Baxter and traditional Hillrom portfolios continues to be strong.
  • We initiate coverage on the stock of Baxter International with a ‘Buy’ rating.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars